Ferrer, Poirot & Wansbrough Helps Win $1.25 Million Verdict for Pradaxa Victim
A federal jury recently awarded $1.25 million to the family of an 84-year-old woman who died after taking Pradaxa after it found that Boehringer Ingelheim Pharmaceuticals Inc. didn’t properly disclose the risks associated with the medication.
Drug injury lawyers at Ferrer, Poirot & Wansbrough are proud to have served on the family’s legal counsel during this landmark case. The family was awarded $50,000 for the woman’s medical expenses, $200,000 for pain and suffering, and an additional $1 million in punitive damages.
Pradaxa is an anti-coagulant that’s designed to treat patients who are at risk of stroke and blood clots. However, the drug can lead to uncontrolled bleeding. In addition, Pradaxa’s manufacturer never told patients or their doctors about the importance of having anti-coagulant levels in the blood checked, which led to some patients having excess levels of the drug in their bodies. Elevated levels can increase the risk of bleeding-related injuries and deaths.
Nearly 3,000 additional cases related to Pradaxa injuries and deaths are pending nationwide.
If you or someone you love was hurt by Pradaxa or any other potentially dangerous drug, our legal team is here to help. Call us today for a free consultation.